Suggested to be a tumor suppressor, down regulation of the claudin 1 gene (CLDN1) has been associated with estrogen receptor (ER) positivity [18] and poor prognosis in invasive breast cancer [15]. This evidence concerns the gene ESR1 and neoplasm.